The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib plus anlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer with concurrent gene alterations: A single-arm, prospective, multicenter phase II study.
 
Guanming Jiang
No Relationships to Disclose
 
Xiaojun Yang
No Relationships to Disclose
 
Jieyun Xie
No Relationships to Disclose
 
Xinpei Yu
No Relationships to Disclose
 
Shiyuan Chen
No Relationships to Disclose
 
Qinquan Tan
No Relationships to Disclose
 
Yihong Zeng
No Relationships to Disclose
 
Ruinian Zheng
No Relationships to Disclose
 
Liping Li
No Relationships to Disclose
 
Wan Zhang
No Relationships to Disclose
 
Xiumao Yin
No Relationships to Disclose
 
Kejun Liu
No Relationships to Disclose
 
Jun Jia
No Relationships to Disclose